| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.10. | POSITRON CORP - 8-K, Current Report | - | SEC Filings | ||
| 18.08. | POSITRON CORP - 8-K, Current Report | 1 | SEC Filings | ||
| POSITRON Aktie jetzt für 0€ handeln | |||||
| 20.07. | Positron Corporation: Positron Secures Multiple PET-CT Orders Amid Accelerating Shift to Cardiac PET | 1 | GlobeNewswire (USA) | ||
| 30.12.25 | Positron Corporation Raises $2 Million to Expand Market Presence and Growth Initiatives | 315 | GlobeNewswire (Europe) | Buffalo, NY, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (OTC: POSC) (the "Company"), a leading molecular imaging medical device company specializing in Positron Emission Tomography (PET)... ► Artikel lesen | |
| 17.11.25 | Positron Corporation Announces Its Transition to a Reporting SEC Company | 311 | GlobeNewswire (Europe) | Buffalo, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Positron Corporation ("Positron" or the "Company") (OTC: POSC), a leader in molecular imaging technology and services, today announced that it has become... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BUTTERFLY NETWORK | 5,870 | +0,74 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 19.10.2026 | Folgende Wertpapiere werden in den Handel an der Frankfurter Wertpapierbörse (FWB) aufgenommen.
1. US88025U1097 10X GENOMICS INC
2. NL0000852564 AALBERTS NV
3. SE0016589188 ELECTROLUX AB
4. SE0000115446... ► Artikel lesen | |
| VYOME | 1,540 | 0,00 % | Vyome Welcomes Jerry Leonard as New Chief Financial Officer | ||
| DIAGNOSTEAR TECHNOLOGIES | 0,133 | +8,13 % | DiagnosTear Technologies Inc.: DiagnosTear Announces Positive Final Results from Clinical Study Demonstrating Strong Diagnostic Performance of TeaRx Red Eye for Detecting Total Tear IgE as a Biomarker for Allergic conjunctivitis | Final study results demonstrate 89% sensitivity, 83.3% specificity compared with quantitative ELISA reference testing for IgE detection.Vancouver, British Columbia--(Newsfile Corp. - September 10, 2026)... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 14,550 | -0,07 % | LifeStance Health Prices Secondary Public Offering Of 45 Mln Shares At $13.12/Shr | ||
| GENEDX | 54,93 | +0,18 % | Why GeneDx Holdings Stock Just Dropped 16.6% | ||
| BRIGHTSPRING HEALTH SERVICES | 72,51 | +0,03 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BILLIONTOONE | 112,12 | 0,00 % | BTIG reiterates Buy on BillionToOne stock, keeps $130 target | ||
| BASEL MEDICAL GROUP | 1,900 | -1,55 % | Morning Market Movers: Aehr Test Systems, Pentair, NextCure, Basel Medical Group See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| FRESENIUS | 53,64 | +0,32 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius Q3/2026 | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Quartalsergebnis
Fresenius Q3/2026 (News mit Zusatzmaterial)
04.11.2026 / 06:45 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 1,850 | 0,00 % | Autonomix Medical, Inc.: Autonomix Medical Granted New U.S. Patent Strengthening Proprietary Catheter-Based Sensing Technology | ||
| PROGYNY | 36,450 | +0,05 % | Progyny, Inc. - 10-Q, Quarterly Report | ||
| SIEMENS HEALTHINEERS | 43,080 | +0,33 % | EQS-AFR: Siemens Healthineers AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Siemens Healthineers AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Siemens Healthineers AG: Vorabbekanntmachung... ► Artikel lesen | |
| ADAPTHEALTH | 7,720 | 0,00 % | AdaptHealth auf der UBS Global Healthcare Conference: Trendwende bei Kaiser Permanente leitet Konsolidierungsphase ein | ||
| PROCEPT BIOROBOTICS | 23,070 | 0,00 % | Procept BioRobotics outlines $390M-$410M 2026 revenue, while targeting positive adjusted EBITDA in Q4 | ||
| STARLING ONCOLOGY INSTITUTE | 4,320 | -0,46 % | Starling Oncology expects $650M-$660M revenue and $4M-$6M adjusted EBITDA in 2026 while targeting 100% capitated revenue growth in 2027 |